CADL – candel therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients [Yahoo! Finance]
Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients
Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment [Yaho
Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment
Bears are Losing Control Over Candel Therapeutics (CADL), Here's Why It's a 'Buy' Now [Yahoo! Finance]
Form 8-K Candel Therapeutics, For: Mar 26
Form 4 Candel Therapeutics, For: Mar 18 Filed by: Nichols William Garrett
Form 4 Candel Therapeutics, For: Mar 18 Filed by: Barone Francesca
Form 4 Candel Therapeutics, For: Mar 18 Filed by: Tak Paul Peter
Form 4/A Candel Therapeutics, For: Mar 17 Filed by: Tyagarajan Seshu
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.